SCHEMBL9008201

SCHEMBL9008201

CCCC[C@]1(O)[C@@H]([C@H](O)CO)OC(O)[C@@H]1O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9008205 1.00 GAA (0.32) GAA
SCHEMBL5682292 0.84 GBA1 (0.33) GAA
SCHEMBL9008126 0.72 LMNA (0.34)
SCHEMBL9151028 0.70 MANBA (0.31)
SCHEMBL9151038 0.70 MANBA (0.31)
SCHEMBL10822077 0.70 LMNA (0.34)
SCHEMBL7439913 0.70 LMNA (0.34)
SCHEMBL16149343 0.63
SCHEMBL30750891 0.61 GAA (0.33) GAA
SCHEMBL18870141 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5491152-A Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-02-13 US disclosed